- Home
- SYBX vs GP Comparison
SYBX vs GP Comparison
Compare SYBX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- GP
- Stock Information
- Founded
- SYBX N/A
- GP 2010
- Country
- SYBX United States
- GP Canada
- Employees
- SYBX N/A
- GP N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- SYBX Health Care
- GP Consumer Discretionary
- Exchange
- SYBX Nasdaq
- GP Nasdaq
- Market Cap
- SYBX 11.8M
- GP 12.7M
- IPO Year
- SYBX N/A
- GP 2020
- Fundamental
- Price
- SYBX $1.16
- GP $0.45
- Analyst Decision
- SYBX
- GP Strong Buy
- Analyst Count
- SYBX 0
- GP 2
- Target Price
- SYBX N/A
- GP $2.33
- AVG Volume (30 Days)
- SYBX 13.5K
- GP 63.5K
- Earning Date
- SYBX 05-13-2025
- GP 02-14-2025
- Dividend Yield
- SYBX N/A
- GP N/A
- EPS Growth
- SYBX N/A
- GP N/A
- EPS
- SYBX N/A
- GP N/A
- Revenue
- SYBX $8,000.00
- GP $20,656,035.00
- Revenue This Year
- SYBX N/A
- GP N/A
- Revenue Next Year
- SYBX N/A
- GP $94.25
- P/E Ratio
- SYBX N/A
- GP N/A
- Revenue Growth
- SYBX N/A
- GP N/A
- 52 Week Low
- SYBX $0.90
- GP $0.41
- 52 Week High
- SYBX $1.96
- GP $1.91
- Technical
- Relative Strength Index (RSI)
- SYBX 50.18
- GP 39.45
- Support Level
- SYBX $1.00
- GP $0.42
- Resistance Level
- SYBX $1.10
- GP $0.45
- Average True Range (ATR)
- SYBX 0.10
- GP 0.04
- MACD
- SYBX 0.01
- GP 0.00
- Stochastic Oscillator
- SYBX 84.64
- GP 25.56
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.